Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Polydipsia, Primary

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Polydipsia, Primary in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kazory, A1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Polydipsia, Primary

ArticleYear
Osmoregulatory mechanisms differentiate MDMA-associated hyponatremia from psychogenic polydipsia.
    The Journal of emergency medicine, 2015, Volume: 48, Issue:1

    Topics: Diagnosis, Differential; Hallucinogens; Humans; Hyponatremia; N-Methyl-3,4-methylenedioxyamphetamine

2015